Release test results
99.678%HPLC purity · meets ≥ 99.5% spec
Mass-spec identityConfirmed · 20.12 mg
Related impurities (total)0.322%
Endotoxin<1.0 EU/mg
HPLC retention time4.69 min
MethodHPLC + LC-MS
ResultPass · meets spec
Lot record
CompoundMOTS-C
Presentation20 MG
Lot numberRGX-26-RGNX-1023
COA numberNS-2026-05024
Test date27 Jul 2026
Release date30 Jul 2026
Independent labNordicstar Labs
StatusCurrent
MOTS-C — lot history
| Lot | Presentation | Tested | HPLC purity | Status |
|---|---|---|---|---|
| RGX-26-RGNX-1022 | 10 MG | Jul 28, 2026 | 99.640% | Current |
| RGX-26-RGNX-1023 this lot | 20 MG | Jul 27, 2026 | 99.678% | Current |
| RGX-26-RGNX-1024 | 30 MG | Jul 27, 2026 | 99.716% | Current |
| RGX-26-RGNX-1025 | 40 MG | Jul 26, 2026 | 99.754% | Current |
| RGX-26-RGNX-778 | 10 MG | Apr 23, 2026 | 99.592% | Superseded |
| RGX-26-RGNX-775 | 40 MG | Apr 18, 2026 | 99.699% | Superseded |
| RGX-26-RGNX-777 | 20 MG | Apr 15, 2026 | 99.630% | Superseded |
| RGX-26-RGNX-776 | 30 MG | Apr 13, 2026 | 99.706% | Superseded |
| RGX-26-RGNX-676 | 30 MG | Jan 18, 2026 | 99.737% | Superseded |
| RGX-26-RGNX-675 | 40 MG | Jan 15, 2026 | 99.592% | Superseded |
| RGX-26-RGNX-678 | 10 MG | Jan 15, 2026 | 99.668% | Superseded |
| RGX-26-RGNX-677 | 20 MG | Jan 12, 2026 | 99.744% | Superseded |
!
Research use only
This lot record documents a research compound sold for laboratory use only — not for human or animal consumption. Results are as tested by Nordicstar Labs; retained samples are archived for five years. Research Use Agreement →